Abstract
Purpose of Review
The diagnosis of Lennox-Gastaut syndrome (LGS), a refractory epileptic encephalopathy, is often made late into disease progression based on the absence of classic EEG abnormalities or typical seizure types at disease onset. The goal of this article is to serve as a general review of LGS for the non-neurologist. As such, we hope to elucidate how a diagnosis is made, highlight novel treatment options, and encourage collaborative treatment decisions between care givers, primary care physicians, neurologists, and psychiatrists.
Recent Findings
Although a relatively limited number of randomized clinical trials have been performed to date, in recent years, two novel antiepileptics, rufinamide and clobazam, have shown promising efficacy in the treatment of this refractory epileptic encephalopathy.
Summary
Ideally, after reading this review, the non-neurologist will feel equipped to recognize suspicion for an epileptic encephalopathy in a pediatric patient and subsequently refer that child to an epileptologist.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Trevathan E, Murphy CC, Yeargin-Allsopp M. Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Epilepsia. 1997:1283–8. doi:10.1111/j.1528-1157.1997.tb00065.x.
Camfield CS, Campfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996:19–23. doi:10.1111/j.1528-1157.1996.tb00506.x.
Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007:1128–32. doi:10.1111/j.1528-1167.2007.01072.x.
Arzimanoglou A, French J, Blume W, Cross H, Ernst J, Feucht M, et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet. 2009;8:82–93. doi:10.1016/S1474-4422(08)70292-8.
Camfield P. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia. 2011:3–9. doi:10.1111/j.1528-1167.2011.03177.x.
Aicardi J, Chevrie JJ. Atypical benign epilepsy of childhood. Dev Med Child Neurol. 1982;24:281–92. doi:10.1111/j.1469-8749.1982.tb13620.x.
Gastaut H, Zifkin BG. Secondary bilateral synchrony and Lennox Gastaut syndrome. In: Niedermeyer E, Degen R, editors. The Lennox Gastaut syndrome. New York: Alan R Liss; 1988.
Gastaut H, Roger J, Soulayrol R, Tassinari CA, Regis H, Dravet C, et al. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox syndrome. Epilepsia. 1966;7:139–79. doi:10.1111/j.1528-1167.1966.tb06263.x.
Chevrie JJ, Aicardi J. Childhood epileptic encephalopathy with slow spike-wave. A statistical study of 80 cases. Epilepsia. 1972;13:259–71. doi:10.1111/j.1528-1157.1972.tb05260.x.
Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde BW, Engel J. ILAE commission report. Glossary of descriptive terminology for ictal semiology: report of the ILAE tast force on classification and terminology. Epilepsia. 2001;42:1212–8. doi:10.1046/j.1528-1157.2001.22001.x.
Livingston JH. The Lennox-Gastaut syndrome. Dev Med Child Neurol. 1988;30:536–40. doi:10.1111/j.1469-8749.1988.tb04782.x.
Scheffer IE, Berkovic SF, Capovilla G, Connolly MB, Guilhoto L, Hirsch E, et al. The organization of the epilepsies: report of the ILAE commission on classification and terminology. International League Against Epilepsy. 2010. http://www.ilae.org . 2016.
Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome. Cochrane Databse Syst Rev. 2003;3:CD003277. doi:10.1002/14651858.CD003277.
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards Subcommittee of the American Academy of neurology and the American Epilelepsy Society. Neurology. 2004;62:1261–73. doi:10.1212/01.WNL.0000123695.22623.32.
French J, Smith M, Faught E, Brown L. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy—report of the quality standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 1999;40:803–8. doi:10.1212/WNL.52.8.1540.
Arzimanoglou A, Guerrini R, Aircardi J. Lennox-Gastaut syndrome. In: Aircardi J, editor. Epilepsy in children. Philadelphia: Lippincott Williams & Wilkins; 2004.
Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord. 2007;9:353–412. doi:10.1684/epd.2007.0144.
Wheless JW, Clarke DR, Carpenter D. Treatment of pediatric epilepsy: expert opinion. J Child Neurol. 2005;20:S1–56. doi:10.1177/088307380502000101.
Arroyo S. Rufinamide. Neurotherapeutics. 2007;4:155–62. doi:10.1016/j.nurt.2006.11.006.
Glauser TA, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;71:1950–8. doi:10.1212/01.wnl.0000303813.95800.0d.
Kluger G, Glauser T, Krauss G, Seeruthun R, Perdomo C, Arroyo S, et al. Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study. Acta Neurol Scand. 2010;122:202–8. doi:10.1111/j.1600-0404.2010.01334.x.
Isojarvi J, Lee D, Peng G, Sperling M. Clobazam-treated patients with Lennox-Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012. Epilepsia. 2016;57(6):e113–6. doi:10.1111/epi.13388. Post-hoc analysis of phase 3 data collected on a randomized multicenter double blinded placebo-controlled study revealed a reduced likelihood of seizure-related injuries in children taking clobazam as compared to placebo.
Ng YT, Conry JA, Drummon R, et al. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011;77:1473–81. doi:10.1212/WNL.0b013e318232de76.
Frost M, Gates J, Helmers SI, et al. Vagal nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia. 2001;42:1148–52. doi:10.1046/j.1528-1157.2001.23900.x.
Freeman JM, Vining EP. Seizures decrease rapidly after fasting: preliminary studies with the ketogenic diet. Arch Pediatr Adoles Med. 1999;53:946–9. doi:10.1001/archpedi.153.9.946.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Marisa S. Prelack and Marissa P. DiGiovine declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Neurology
Rights and permissions
About this article
Cite this article
Prelack, M.S., DiGiovine, M.P. Lennox-Gastaut Syndrome: a Current Review. Curr Pediatr Rep 5, 13–16 (2017). https://doi.org/10.1007/s40124-017-0117-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40124-017-0117-8